Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Case Report



A Twelve-year-old female patient developing anaphylaxis during the initial phase of conventional immunotherapy: a case report

Mehmet semih Demirtas; Erdem Topal; Ferhat Catal.

Abstract
Allergen specific immunotherapy is administered to asthmatic patients and allergic rhinitis treatment. Local and systemic reactions can occur after administration of allergen specific immunotherapy. Our case was a patient with allergic rhinoconjunctivitis whose complaints could not be controlled by medical treatment and eventually subcutaneous immunotherapy was administered. Approximately ten minutes after subcutaneous injection during the initial phase of conventional immunotherapy, the patient developed shortness of breath, cough and pruritus and was diagnosed with anaphylaxis due to immunotherapy. We aim to emphasize that severe systemic reactions (anaphylaxis) can occur due to immunotherapy injections which are effectively used in the treatment of allergic rhinitis and asthma.

Key words: Anaphylaxis;Immunotherapy;Initial Phase



Share this Article


Advertisement
Progress in Orthopedic Science

SUBMIT YOUR ARTICLE NOW


ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Article Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons